152 related articles for article (PubMed ID: 29411964)
21. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice.
Dalela M; Shrivastav TG; Kharbanda S; Singh H
ACS Appl Mater Interfaces; 2015 Dec; 7(48):26530-48. PubMed ID: 26528585
[TBL] [Abstract][Full Text] [Related]
22. Anti-EGFR lipid micellar nanoparticles co-encapsulating quantum dots and paclitaxel for tumor-targeted theranosis.
Kang SJ; Jeong HY; Kim MW; Jeong IH; Choi MJ; You YM; Im CS; Song IH; Lee TS; Park YS
Nanoscale; 2018 Nov; 10(41):19338-19350. PubMed ID: 30307008
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
24. Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles.
Shimada T; Ueda M; Jinno H; Chiba N; Wada M; Watanabe J; Ishihara K; Kitagawa Y
Anticancer Res; 2009 Apr; 29(4):1009-14. PubMed ID: 19414339
[TBL] [Abstract][Full Text] [Related]
25. Nanomedicine-based paclitaxel induced apoptotic signaling pathways in A562 leukemia cancer cells.
Wang Y; Zhou L; Xiao M; Sun ZL; Zhang CY
Colloids Surf B Biointerfaces; 2017 Jan; 149():16-22. PubMed ID: 27716527
[TBL] [Abstract][Full Text] [Related]
26. Thermosensitive hydrogel system assembled by PTX-loaded copolymer nanoparticles for sustained intraperitoneal chemotherapy of peritoneal carcinomatosis.
Xu S; Fan H; Yin L; Zhang J; Dong A; Deng L; Tang H
Eur J Pharm Biopharm; 2016 Jul; 104():251-9. PubMed ID: 27185379
[TBL] [Abstract][Full Text] [Related]
27. Ovarian Cancer Therapy by VSVMP Gene Mediated by a Paclitaxel-Enhanced Nanoparticle.
Long J; Yang Y; Kang T; Zhao W; Cheng H; Wu Y; Du T; Liu B; Li Y; Luo F; Gou M
ACS Appl Mater Interfaces; 2017 Nov; 9(45):39152-39164. PubMed ID: 28944654
[TBL] [Abstract][Full Text] [Related]
28. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines.
Bernabeu E; Gonzalez L; Cagel M; Gergic EP; Moretton MA; Chiappetta DA
Colloids Surf B Biointerfaces; 2016 Apr; 140():403-411. PubMed ID: 26780253
[TBL] [Abstract][Full Text] [Related]
29. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
Yu DH; Lu Q; Xie J; Fang C; Chen HZ
Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
[TBL] [Abstract][Full Text] [Related]
30. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations.
Zhang Z; Wang X; Li B; Hou Y; Yang J; Yi L
Drug Deliv; 2018 Nov; 25(1):166-177. PubMed ID: 29299936
[TBL] [Abstract][Full Text] [Related]
31. Anti-tumor activity of biodegradable polymer-paclitaxel conjugate micelles on Lewis lung cancer mice models.
Wan Y; Zheng Y; Song X; Hu X; Liu S; Tong T; Jing X
J Biomater Sci Polym Ed; 2011; 22(9):1131-46. PubMed ID: 20594407
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-630 inhibitor sensitizes chemoresistant ovarian cancer to chemotherapy by enhancing apoptosis.
Eoh KJ; Lee SH; Kim HJ; Lee JY; Kim S; Kim SW; Kim YT; Nam EJ
Biochem Biophys Res Commun; 2018 Mar; 497(2):513-520. PubMed ID: 29452092
[TBL] [Abstract][Full Text] [Related]
33. Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer.
Devalapally H; Duan Z; Seiden MV; Amiji MM
Int J Cancer; 2007 Oct; 121(8):1830-8. PubMed ID: 17557285
[TBL] [Abstract][Full Text] [Related]
34. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
[TBL] [Abstract][Full Text] [Related]
35. Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells.
Zhang J; Wang L; Fai Chan H; Xie W; Chen S; He C; Wang Y; Chen M
Sci Rep; 2017 May; 7():46057. PubMed ID: 28470171
[TBL] [Abstract][Full Text] [Related]
36. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers.
Gawde KA; Sau S; Tatiparti K; Kashaw SK; Mehrmohammadi M; Azmi AS; Iyer AK
Colloids Surf B Biointerfaces; 2018 Jul; 167():8-19. PubMed ID: 29625422
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.
Jeong JY; Kang H; Kim TH; Kim G; Heo JH; Kwon AY; Kim S; Jung SG; An HJ
Cancer Lett; 2017 Feb; 386():168-178. PubMed ID: 27887917
[TBL] [Abstract][Full Text] [Related]
39. Paclitaxel-loaded polyester nanoparticles prepared by spray-drying technology: in vitro bioactivity evaluation.
López-Gasco P; Iglesias I; Benedí J; Lozano R; Teijón JM; Blanco MD
J Microencapsul; 2011; 28(5):417-29. PubMed ID: 21736526
[TBL] [Abstract][Full Text] [Related]
40. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]